Inhibition of p53 attenuates steatosis and liver injury in a mouse model of non-alcoholic fatty liver disease.


BACKGROUND & AIMS p53 and its transcriptional target miRNA34a have been implicated in the pathogenesis of fatty liver. We tested the efficacy of a p53 inhibitor, pifithrin-α p-nitro (PFT) in attenuating steatosis, associated oxidative stress and apoptosis in a murine model of non-alcoholic fatty liver disease (NAFLD). METHODS C57BL/6 mice were fed a high… (More)
DOI: 10.1016/j.jhep.2012.11.042


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics